pntd.0010606
pntd.0010606
RESEARCH ARTICLE
Author summary
Taenia solium cysticercosis (TSC) is a neglected tropical disease caused by the larval stage
of T. solium. The disease is a serious threat to public health, especially in low-income
countries and is associated with poor pig husbandry practices, deficient hygiene and sani-
tation, close contact between humans and pigs, lack of slaughter facilities for pigs and
inadequate meat inspection. When the larva of T. solium lodges in the human central ner-
vous system, the disease is called neurocysticercosis (NCC). The most frequent neurologi-
cal manifestations of NCC are epileptic seizures and epilepsy. NCC diagnosis remains a
challenge in low-income countries and its relationship with neurological signs/symptoms
so far was not studied in Mocuba, located in Zambézia province, one of the districts with
the biggest pig populations in Mozambique. In this study we investigated the seropreva-
lence for TSC, risk factors for infection and the association with neuropsychiatric (= neu-
rological and psychiatric) disorders. Seroprevalence of TSC was 10.3%, and was associated
with chronic headache. Moreover, increasing age was associated with Ag-ELISA seroposi-
tivity. Future studies are needed applying in-depth clinical examination, and additional
serological, molecular biological and radiological diagnostic tools in order to confirm (or
not) the results of our study.
Introduction
Taenia solium cysticercosis (TSC) is a foodborne, zoonotic and neglected tropical disease
(NTD), caused by the larval stage (cysticercus) of T. solium. The disease is emerging as a seri-
ous threat to public health, inflicting significant economic losses and disabilities in low-income
countries of sub-Saharan Africa, Latin America and Asia where T. solium is endemic. It is also
Methods
Ethics statement
The present study was approved by the Mozambique National Bioethical Committee of Health
(51/CNBS/2017) and by the administrative authorities from Zambézia province and commu-
nity leaders. The study also received approval from the ethics committee of the Klinikum
rechts der Isar, Technical University of Munich, Germany (537/18 S-KK).
Prior to the interviews and blood sampling, written consent were obtained from the enrolled
participants. Written consent from children aged below 12 years and illiterate participants were
obtained in the presence of a guardian or witness, who signed on their behalf. For participants
aged between 12 and 17 years a written assent was obtained in addition to their parents’ consent.
Each participant was assigned a unique identification study number and all data and samples
were handled confidentially using this study number from this point onward.
Participants who suffered from epileptic seizures/epilepsy or other neuropsychiatric disor-
ders were referred to the local health centre for diagnosis confirmation and follow-up accord-
ing to the Mozambique Ministry of Health guidelines [16].
Fig 1. Location of the study area. Created by Patricia Noormahomed based on EarthExplorer (https://earthexplorer.usgs.gov).
https://doi.org/10.1371/journal.pntd.0010606.g001
an example, the district has an HIV prevalence of 9% and 39% of children are infected by at
least one intestinal parasite [17–21].
member was available in a selected household, either by absence or refusals of other members,
participants were recruited from the nearest household. Inclusion criteria were living in the
household and being at least 2 years old. People who had taken alcoholic beverages in the pre-
vious 24 hours were excluded. In total, 1,086 participants from 565 households were included
in the study.
consciousness or before loss of consciousness. For the latter, we also asked about warning
signs such as a strange smell (aura) before the epileptic seizure.
Blood sampling
A 5 ml sample of venous blood was obtained by venepuncture from each of the recruited indi-
viduals after consenting [26]. The samples were immediately stored in cooling boxes at 4˚C
and transported to the Mocuba district Hospital Laboratory, where they were centrifuged for 5
min at 1500 r.p.m. to obtain serum. Serum was stored at -20˚C until shipment to the Parasitol-
ogy Laboratory at Faculty of Medicine, Eduardo Mondlane University (UEM) in Maputo
where samples were stored at -80˚C until further processing.
Serological testing
T. solium circulating antigens (Ag) were detected using the monoclonal antibody based
B158C11A10 Enzyme Linked Immunosorbent Assay (Cysticercosis Ag-ELISA, ApDia, Bel-
gium). Ag index was calculated as the mean of optical density (OD) of each serum sample
divided by the cut-off. In addition, IgG antibodies (Ab) against T. solium larva were deter-
mined via Western Blot (LDBIO Diagnostic, Lyon, France). A sample was considered positive
if at least 2 bands (6–8 kDa; 12 kDa; 23–26 kDa; 39 kDa; 50–55 kDa) were visible, according to
the manufacturer’s instructions.
Statistical analysis
Data were captured in EpiData Entry Client version 4.3 and analysed using STATA version
13.0 (Stata Corp., College Station, TX). Descriptive analyses were first performed by calculat-
ing frequencies and percentages for categorical variables. Age was categorized into age groups
(2–14, 15–24, 25–54 and >55 years) for the purpose of analysis. Using Chi-square test, bivari-
ate analysis was performed to assess associations between a positive Ag-ELISA and/or Western
Blot assay results and several factors. These factors included: socio-demographic and neuro-
psychiatric diseases; knowledge about T. solium; transmission risk-related variables and pig
management variables. Chi-square tests were also used to assess difference in seroprevalence
by district. Logistic regression models were performed to assess the association of seropreva-
lence of T. solium with the four vignettes. Models were run unadjusted and adjusted for age,
gender, education and occupation. The significance level was set at p<0.05.
Results
Among the 1,086 participants included in the study, the age ranged from 2 to 87 years, with a
median age of 25 years. A total of 656 participants (60.4%) were predominantly farmers, 640
(58.9%) were female, and the majority 763 (70.3%) attended primary school. A total of 237
(21.8%) participants reported outdoor defecation, 806 (74.2%) reported eating pork, 155
(14.3%) were pig keepers and 105 (9.7%) have heard about the pork tapeworm (Table 1).
The results of cysticercosis serological screening either for antigen or antibody detection or
both from each village are shown in Fig 3. Overall, out of the 1,086 samples tested, 112 (10.3%)
were positive in at least one serological test; 54 (4.9%) had circulating antigens and 72 (6.6%)
had circulating antibodies to T. solium larva. Moreover, 14 (1.3%) were positive in both tests.
A wide variation of seropositivity was observed across different villages ranging from 3.6% in
Alto Benfica village to 17.7% in Mocuba Municipality (p = 0.007).
Fig 3. Prevalence of human cysticercosis according to each study village in Mocuba district.
https://doi.org/10.1371/journal.pntd.0010606.g003
In general, the seroprevalence of Ab tended to be higher (ranging from 3.6% in Alto Benfica
village to 9.5% in Mocuba Municipality) than that of Ag (ranging from 0% in Munhiba to
8.2% in Mocuba Municipality; p<0.005). The details about serological assay results from each
of the studied villages can be seen in Fig 3.
The analysis of socio-demographic variables in relation to the cysticercosis serological
assays are presented in Table 2. Seropositivity for antigen or antibody increased with age and
was lowest for children under the age of 15 years (p = 0.03). Seropositivity was not statistically
significantly different between males and females (11.7% versus 9.4%, p = 0.22), nor between
the levels of education (p = 0.12).
The findings concerning the assessment of clinical signs and symptoms related to neuro-
psychiatric disorders in relation to socio-demographic factors are presented in Table 3. A
total of 530 (49.5%) participants screened positive for vignette 1. More males screened posi-
tive than females (p = 0.02). Education was not associated with screening positive but farm-
ers more commonly screened positive than people with other occupations (p = 0.05).
Overall, 293 participants (27%) screened positive for vignette 2; positivity decreased with
increasing age and was similar for males and females. Vignette 3 was positive in 188 (18%)
of the participants and vignette 4 in 183 (18.3%). Vignette 4 was more commonly positive
among participants older than 14 years and was more commonly positive among farmers.
Of the total vignettes, chronic headache was associated with cysticercosis seropositivity
(p = 0.013) (Table 4).
Discussion
Our results indicate that T. solium antigens and antibodies were present in 10.3% of the study
participants from Mocuba district. Moreover, chronic headache presented a significant associ-
ation with cysticercosis seropositivity (p = 0.013), although neuropsychiatric disorders such as
epileptic seizures/epilepsy and psychosis presented no significant association. These findings
suggest that TSC is prevalent in Mocuba and chronic headache prevails as an important
Table 2. Socio-demographic data and relation with serological assays to T. solium larva antigens and antibodies.
Variables Study participants n (%) Ag-Elisa + Western blot + Ag-Elisa + and Western blot + Ag-Elisa + or Western
blot +
n (%) n (%) n (%) n (%) p-value
Total 1086 54 (4.9) 72 (6.6) 14 (1.3) 112 (10.3)
Age group (years)
2–14 277 4 (1.4) 13 (4.7) 1 (0.4) 16 (5.8) 0.03
15–24 251 12 (4.8) 17 (6.8) 1 (0.4) 28 (11.2)
25–54 457 30 (6.6) 37 (8.1) 10 (2.2) 57 (12.5)
�55 101 8 (7.9) 5 (5.0) 2 (2) 11 (10.9)
Gender
Female 640 26 (4.1) 42 (6.6) 6 (1.3) 60 (9.4) 0.22
Male 446 28 (6.3) 30 (6.7) 8 (1.3) 52 (11.7)
Level of education
No formal education 197 5 (2.5) 7 (3.6) 0 (0) 12 (6.1) 0.12
Primary 763 40 (5.2) 55 (7.2) 14 (1.8) 81 (10.6)
Secondary or higher 121 9 (7.4) 10 (8.3) 0 (0) 19 (15.7)
Other 5 0 (0.0) 0 (0.0) 0 (0) 0 (0.0)
Occupation
Farmer 656 38 (5.8) 43 (6.6) 11 (1.7) 70 (10.7) 0.63
Other 430 16 (3.7) 29 (6.7) 3 (0.7) 42 (9.8)
Water source
River 82 7 (8.5) 5 (6.1) 3 (3.7) 9 (11.0) 0.67
Well 585 28 (4.8) 43 (7.4) 6 (1) 65 (11.1)
Borehole 405 19 (4.7) 22 (5.4) 5 (1.2) 36 (8.9)
Tap 14 0 (0.0) 2 (14.3) 0 (0) 2 (15.4)
Faecal disposal
Latrine 849 47 (5.5) 56 (6.6) 13 (1.5) 90 (10.6) 0.56
Outdoor defecation 237 7 (3.0) 16 (6.8) 1 (0.4) 22 (9.3)
Pork consumption
Yes 806 43 (5.3) 57 (7.1) 3 (1.1) 89 (11.0) 0.18
No 280 11 (3.9) 15 (5.4) 11 (1.4) 23 (8.2)
Pork preparation
Boiled 452 21 (4.6) 29 (6.4) 7 (1.5) 43 (9.5) 0.13
Grilled 345 22 (6.4) 28 (8.1) 4 (1.2) 46 (13.3)
Not specified 9 0 (0.0) 0 (0.0) 0 (0) 0 (0.0)
Source of pork
Informal market 747 41 (5.5) 52 (7.0) 10 (1.3) 83 (11.1) 0.88
Butchery 2 0 (0.0) 0 (0.0) 0 (0) 0 (0.0)
Other 56 2 (3.6) 5 (8.9) 1 (1.8) 6 (10.7)
Pig keeping
Yes 155 10 (6.5) 14 (9.3) 3 (1.9) 21 (13.5) 0.15
No 931 44 (4.7) 58 (6.2) 11 (1.2) 91 (9.8)
Pig husbandry system
Confinement 52 6 (11.5) 4 (7.7) 1 (1.9) 9 (17.3) 0.33
Free ranging 103 4 (3.9) 10 (9.7) 2 (1.9) 12 (11.7)
Ever heard about the tapeworm
Yes 105 2 (1.9) 6 (5.7) 1 (1) 7 (6.7) 0.20
No 981 52 (5.3) 66 (6.7) 13 (1.3) 105 (10.7)
https://doi.org/10.1371/journal.pntd.0010606.t002
Table 3. Assessment of clinical signs and symptoms related to neuropsychiatric disorders in relation to socio-demographic factors.
Variables Study participants n (%) Vignette 1 (Chronic Vignette 2 (Tonic Vignette 3 (Focal Vignette 4 (Psychotic
headache) clonic seizure) seizure) disorder)
n (%) p-value n (%) p-value n (%) p-value n (%) p-value
Total 1086 530/1070 (49.5) 293/1086 (27) 188/1042 (18) 183/999 (18.3)
Age group (years)
2–14 277 123/268 (45.9) 0.47 89/277 (32.1) <0.01 45/251 (17.9) 0.55 23/219 (10.5) <0.01
15–24 251 125/247 (50.6) 73/251 (29.1) 48/247 (19.4) 49/242 (20.2)
25–54 457 227/454 (50) 116/457 (25.4) 82/444 (18.5) 92/441 (20.9)
�55 101 55/101 (54.5) 15/101 (14.9) 13/100 (13) 19/97 (19.6)
Gender
Female 446 197/438 (45) 0.02 128/446 (28.7) 0.32 72/424 (17) 0.51 84/407 (20.6) 0.14
Male 640 333/632 (52.7) 165/640 (25.8) 116/618 (18.8) 99/592 (16.7)
Level of education
No formal education 197 96/187 (51.3) 0.74 60/197 (30.5) 0.58 36/181 (19.9) 0.90 23/157 (14.6) 0.39
Primary 763 377/757 (49.8) 199/763 (26.1) 132/743 (17.8) 136/718 (18.9)
Secondary or higher 121 55/121 (45.5) 32/121 (26.4) 19/113 (16.8) 24/119 (20.2)
Other 5 2/5 (40) 2/5 (40) 1/5 (20) 0/5 (0)
Occupation
Farmer 656 338/650 (52) 0.05 162/656 (24.7) 0.04 113/646 (17.5) 0.61 130/635 (20.5) 0.03
Other 430 192/420 (45.7) 131/430 (30.5) 75/396 (18.9) 53/364 (14.6)
Water source
River 82 41/79 (51.9) 0.80 23/82 (28) 0.77 19/77 (24.7) 0.24 12/73 (16.4) 0.73
Well 585 292/582 (50.2) 165/585 (28.2) 102/560 (18.2) 104/531 (19.6)
Borehole 405 190/395 (48.1) 101/405 (24.9) 63/392 (16.1) 66/382 (17.3)
Tap 13 7/13 (53.8) 4/13 (30.8) 4/12 (33.3) 1/12 (8.3)
Other 1 0/1 (0) 0/1 (0) 0/1 (0) 0/1 (0)
Faecal disposal
Latrine 820 396/810 (48.9) 0.57 220/820 (26.8) 0.88 138/784 (17.6) 0.62 132/765 (17.3) 0.13
Outdoor defecation 237 121/231 (52.4) 64/237 (27) 46/230 (20) 43/208 (20.7)
Other 29 13/29 (44.8) 9/29 (31) 4/28 (14.3) 8/26 (30.8)
Pork consumption
Yes 280 127/276 (46) 0.20 64/280 (22.9) 0.08 40/269 (14.9) 0.14 43/260 (16.5) 0.44
No 806 403/794 (50.8) 229/806 (28.4) 148/773 (19.1) 140/739 (18.9)
Pork preparation
Boiled 452 192/446 (43) <0.001 113/452 (25) 0.04 72/431 (16.7) 0.15 62/411 (15.1) <0.01
Grilled 345 208/341 (61) 112/345 (32.5) 74/333 (22.2) 77/320 (24.1)
Not specified 9 3/7 (42.9) 4/9 (44.4) 2/9 (22.2) 1/8 (12.5)
Source of pork
Informal market 747 372/736 (50.5) 0.36 211/747 (28.2) 0.08 136/719 (18.9) 0.49 128/688 (18.6) 0.44
Butchery 2 2/2 (100) 2/2 (100) 1/2 (50) 0/2 (0)
Other 56 29/55 (52.7) 16/56 (28.6) 11/51 (21.6) 12/48 (25)
Pig keeping
Yes 155 66/153 (43.1) 0.11 44/155 (28.4) 0.74 27/146 (18.5) 0.97 31/146 (21.2) 0.39
No 931 464/917 (50.6) 249/931 (26.7) 161/896 (18) 152/853 (17.8)
Pig husbandry system
Confinement 52 21/52 (40.4) 0.75 15/52 (28.8) 1 9/49 (18.4) 1 9/50 (18) 0.63
Free ranging 103 45/101 (44.6) 29/103 (28.2) 18/97 (18.6) 22/96 (22.9)
Ever heard about the tapeworm
Yes 105 47/103 (45.6) 0.47 34/105 (32.4) 0.23 26/101 (25.7) 0.05 20/102 (19.6) 0.83
No 981 483/967 (49.9) 259/981 (26.4) 162/941 (17.2) 163/897 (18.2)
https://doi.org/10.1371/journal.pntd.0010606.t003
Table 4. Analysis of statistical association between screening positive for vignettes and cysticercosis serology positivity.
Variables Study participants n Ag-ELISA+ or Western
(%) blot+
n (%) Unadjusted Odds Ratio (95% p-value Adjusted Odds Ratio (95% p-value
CI) CI)⸸
Total 1086 112 (10.3)
Vignette 1 (Chronic
headache)
No 540 69 (12.8) Reference 0.013 Reference 0.018
Yes 530 43 (8.1) 0.6 (0.4–0.9) 0.61 (0.41–0.91)
Vignette 2 (Tonic clonic
seizure)
No 793 85 (10.7) Reference 0.47 Reference 0.59
Yes 293 27 (9.2) 0.85 (0.53–1.32) 0.88 (0.55–1.38)
Vignette 3 (Focal seizure)
No 854 89 (10.4) Reference 0.93 Reference 0.90
Yes 188 20 (10.6) 1.02 (0.6–1.68) 1.04 (0.6–1.71)
Vignette 4 (Psychotic
disorder)
No 816 87 (10.7) Reference 0.91 Reference 0.62
Yes 183 19 (10.4) 0.97 (0.56–1.61) 0.88 (0.5–1.46)
https://doi.org/10.1371/journal.pntd.0010606.t004
disorder in seropositive patients. To the best of our knowledge, this was the first pilot study
performed in the country, particularly in Mocuba district with the aim to generate baseline
information about seroprevalence and risk factors for human cysticercosis, and its possible
relationship with some selected neuropsychiatric disorders. There were several important find-
ings from our study.
Serology
Our findings revealed that human cysticercosis was prevalent in the setting of our study
(10.3%), although lower than previously reported in Angónia district and Beira city, Central
Mozambique [14,15]. The prevalence is still worrying as it demonstrates the potential for a
greater spread of the disease, which can be caused by several factors, including hygiene and
sanitation. The higher prevalence in some municipalities such as Mocuba (17.7%) in compari-
son with those with lower prevalences (e.g. Alto Benfica, 3.6%), may be explained by sociode-
mographic factors, which should be analysed in future studies.
Previous studies from Mozambique found in general higher prevalence of either antigens
(15%) or antibodies (10%) to T. solium larva than the ones reported in this study [14,15], and
were consistent with studies done in other settings such as Cameroon [27], Nigeria [28], Viet-
nam [29,30], Zambia [31] and Democratic Republic of Congo [5], which reported similar sero-
prevalence rates. In our study, only 12.5% of the screened sera tested simultaneously positive
to both serological assays. The differences in the prevalence of antigens (4.9%), that indicates a
current infection, and antibodies (6.2%), which indicates a previous or current exposure to
infection, may be influenced by the number, location of cysts and their larval stage. Further-
more, antibodies can persist longer, even after the clearance of the infection, while the presence
of antigens is only detected when viable parasites are present [1–3,10,32,33]. Moreover, the
western blot assay we used detected only three out of the seven glycoproteins described to be
specific for cysticercosis [1,32,34]. So, it is possible that the prevalence of antibodies found in
our study was underestimated.
In addition to that, the differences in study design, HIV serostatus characteristics of the
study participants (immunocompetent or immunocompromised), serological assays used for
each study, and parasite genetic diversity (which ultimately influenced the sensitivity and spec-
ificity of the serological assays) can explain the differences found within studies in the same
region and in other settings [5,9,10,35]. Of note, that to date, we do not have systematic studies
done in Mozambique accessing the existing genetic variants of T. solium, except for the one in
which phylogenetic studies of cysts from Central Mozambique revealed the existence of the
Latin variant [32]. As Mozambique has been exposed to migration from Europe and Asia, we
cannot exclude the possibility that Mozambique has both variants circulating in different
regions and further studies should be done in order to provide relevant information about this
subject.
found that seropositivity to cysticercal antigens was associated with severe headache
[14,15,42,43]. Nevertheless, in other settings such as in Anzoátegui in Venezuela, Vietnam and
Nabo Village in Tiandong, China, no statistical association was found between these two vari-
ables [44–46]. Our findings may reflect the fact that headache may be correlated to the patho-
genesis of the disease in this study setting.
In addition to the high burden of epileptic seizures and chronic headache, we also found
that psychotic manifestations were highly prevalent in the setting of our study (18.3%), con-
firming the anecdotal reports from the Mocuba district community leaders of having a high
proportion of community residents with those conditions. As with the other two disorders,
psychotic disorders do not seem to be related to cysticercosis seropositivity either. Psychotic
disorders are understudied in Africa, as revealed by a recent scoping review [47], that found
only nine studies in which the prevalence of psychotic disorders was analysed in Africa from
1984 to 2020. The available reports describe a prevalence ranging from 1% to 4.4% in rural
regions. The only published population-based study done in 2003 in a rural (Cuamba) and
urban (Maputo) area of northern and southern Mozambique, respectively, found that seizure
disorders (4.4% vs 1.6%), psychosis (4.4% vs 1.9%) and mental retardation (1.9% vs 1.3%) were
higher in rural compared to urban areas [24] and well below the results of our study and recent
hospital data from Zambézia Provincial Directorate [36]. It is difficult to explain this high bur-
den. Apart from the possibility of other CNS pathogens causing epileptic seizures/epilepsy and/
or psychosis, such as Toxoplasma gondii, Toxocara spp. and Onchocerca volvulus (the latter was
recently identified in Zambézia province) [20,21,48,49], we think that the prolonged armed con-
flict that affected this region for decades in some of the study villages [50,51], combined with
the stress it provokes in the affected population, might be playing a role as causative agent for
this high prevalence of psychosis. Indeed, the effects of armed conflict on mental health within
the affected communities is well documented in the literature, as it causes disruption of socio-
economic and political infrastructure including the appropriate delivery of health care services,
which was the case in our study setting and other regions of Mozambique [50–53].
Other potential risk factors such as consumption of pork [61], pig keeping, use of unsafe
water, faecal disposal and types of latrine were not statistically significant in our study, simi-
larly to the study done in Angónia district [14]. This was expected since the study participants
share the same environmental conditions, and are equally exposed to the same risk factors and
consequently equally exposed to the infection. Furthermore, although there is a fraction of
Muslim people amongst our study participants, we did not expect our findings to be affected
by the religion, since cysticercosis is acquired mainly through water or food contaminated
with T. solium eggs, and consequently anyone can acquire the infection regardless of the con-
sumption of pork meat or professed religion. In some studies, food, water and hygiene related
factors were significantly associated with cysticercosis seropositivity, including consumption
of undercooked pork [44], and using the same water source [43]; although in other studies, fac-
tors such as consumption of raw meat and/or vegetables [30] and hygiene (presence of latrine)
[57] were not associated with cysticercosis seropositivity.
Given the limited value of serology for diagnosis of cysticercosis and NCC and the scarcity
and costliness of imaging techniques in endemic countries, research priorities should be given
to the development of a point-of-care diagnostic tool and/or a biomarker. This should be done
in combination with studies on parasite genetic diversity, and eco-epidemiological as well as
clinical features of cysticercosis/NCC to assess geographic distribution patterns to support sur-
veillance, diagnosis and control of cysticercosis and NCC.
Acknowledgments
We are indebted to the Zambézia Provincial Governor, Dr Abdul Razak Noormahomed, his
team and to the community leaders whose support and collaboration during the field work
was critical for the engagement of the study participants in this research. We also thank the
Mental health Department and the National Public Health Directorate of the Ministry of
Health in Maputo, Mozambique for providing clinical assistance to the participants. Finally,
we are thankful to the study participants who consented to participate in this study.
Author Contributions
Conceptualization: Alberto Pondja, Clarissa Prazeres da Costa, Veronika Schmidt, Andrea S.
Winkler, Emı́lia Virgı́nia Noormahomed.
Data curation: Irene Langa, Fernando Padama, Noémia Nhancupe, Alberto Pondja, Dominik
Stelzle, Emı́lia Virgı́nia Noormahomed.
Formal analysis: Alberto Pondja, Dominik Stelzle, Clarissa Prazeres da Costa, Veronika
Schmidt, Andrea S. Winkler, Emı́lia Virgı́nia Noormahomed.
Funding acquisition: Andrea S. Winkler, Emı́lia Virgı́nia Noormahomed.
Investigation: Irene Langa, Fernando Padama, Noémia Nhancupe, Alberto Pondja, Clarissa
Prazeres da Costa, Veronika Schmidt, Andrea S. Winkler, Emı́lia Virgı́nia Noormahomed.
Methodology: Irene Langa, Fernando Padama, Noémia Nhancupe, Emı́lia Virgı́nia
Noormahomed.
Project administration: Emı́lia Virgı́nia Noormahomed.
Supervision: Irene Langa, Fernando Padama, Noémia Nhancupe, Emı́lia Virgı́nia
Noormahomed.
Writing – original draft: Irene Langa, Fernando Padama, Noémia Nhancupe, Alberto Pondja,
Delfina Hlashwayo, Lidia Gouveia, Dominik Stelzle, Clarissa Prazeres da Costa, Veronika
Schmidt, Andrea S. Winkler, Emı́lia Virgı́nia Noormahomed.
Writing – review & editing: Irene Langa, Fernando Padama, Noémia Nhancupe, Alberto
Pondja, Delfina Hlashwayo, Lidia Gouveia, Dominik Stelzle, Clarissa Prazeres da Costa,
Veronika Schmidt, Andrea S. Winkler, Emı́lia Virgı́nia Noormahomed.
References
1. Carpio A, Fleury A, Romo ML, Abraham R. Neurocysticercosis: the good, the bad, and the missing.
Expert Rev Neurother. 2018; 18:289–301. https://doi.org/10.1080/14737175.2018.1451328 PMID:
29521117
2. Del Brutto OH. Neurocysticercosis in Western Europe: a re-emerging disease? Acta Neurol Belg. 2012;
112:335–343. https://doi.org/10.1007/s13760-012-0068-3 PMID: 22527788
3. Garcia HH, Nash TE, Del Brutto OH. Clinical symptoms, diagnosis, and treatment of neurocysticerco-
sis. Lancet Neurol. 2014; 13:1202–1215. https://doi.org/10.1016/S1474-4422(14)70094-8 PMID:
25453460
4. Nhancupe N, Noormahomed EV, Afonso S, Svard S, Lindh J. Further evaluation of recombinant Tsol-
p27 by enzyme-linked immunoelectrotransfer blot for the serodiagnosis of cysticercosis in pigs from
Mozambique. Parasit Vectors. 2019; 12:564. https://doi.org/10.1186/s13071-019-3816-x PMID:
31775845
5. Mukendi D, Kalo JL, Lutumba P, Barbé B, Jacobs J, Yansouni CP, et al. High frequency of Taenia
solium antigen positivity in patients admitted for neurological disorders in the Rural Hospital of
Mosango, Democratic Republic of Congo. BMC Infect Dis. 2021;17: 21(1):359. https://doi.org/10.1186/
s12879-021-06032-8 PMID: 33865327
6. Flisser A, Madrazo I, Plancarte A, Schantz P, Allan J, Craig P, et al. Neurological symptoms in occult
neurocysticercosis after single taeniacidal dose of praziquantel. Lancet. 1993; 342:748. https://doi.org/
10.1016/0140-6736(93)91743-6 PMID: 8103859
7. Winkler AS. Neurocysticercosis in sub-Saharan Africa: a review of prevalence, clinical characteristics,
diagnosis, and management. Pathog Glob Health. 2012; 106:261–274. https://doi.org/10.1179/
2047773212Y.0000000047 PMID: 23265550
8. Winkler AS, Willingham AL 3rd, Sikasunge CS, Schmutzhard E. Epilepsy and neurocysticercosis in
sub-Saharan Africa. Wien Klin Wochenschr. 2009; 121 Suppl 3:3–12. https://doi.org/10.1007/s00508-
009-1242-3 PMID: 19915809
9. Ndimubanzi PC, Carabin H, Budke CM, Nguyen H, Qian YJ, Rainwater E, et al. A systematic review of
the frequency of neurocyticercosis with a focus on people with epilepsy. PLoS Negl Trop Dis. 2010; 4:
e870. https://doi.org/10.1371/journal.pntd.0000870 PMID: 21072231
10. Garcia HH. Neurocysticercosis. Neurol Clin. 2018; 36:851–864; https://doi.org/10.1016/j.ncl.2018.07.
003 PMID: 30366559
11. Willingham AL 3rd,Engels D. Control of Taenia solium cysticercosis/taeniosis. Adv Parasitol. 2006;
61:509–566. https://doi.org/10.1016/S0065-308X(05)61012-3 PMID: 16735172
12. Winkler AS. Epilepsy and neurocysticercosis in sub-Saharan Africa. In: Foyaca-Sibat H, editor. Novel
aspects on cysticercosis and neurocysticercosis. InTech; 2013; p. 307–340.
13. Afonso SM, Vaz Y, Neves L, Pondja A, Dias G, Willingham AL, et al. Human and porcine Taenia solium
infections in Mozambique: identifying research priorities. Anim Health Res Rev. 2011; 12:123–129.
https://doi.org/10.1017/S1466252311000077 PMID: 21676344
14. Assane YA, Trevisan C, Schutte CM, Noormahomed EV, Johansen MV, Magnussen P. Neurocysticer-
cosis in a rural population with extensive pig production in Angonia district, Tete Province, Mozambique.
Acta Trop. 2017; 165:155–160. https://doi.org/10.1016/j.actatropica.2015.10.018 PMID: 26519884
15. Noormahomed EV, Nhacupe N, Mascaro-Lazcano C, Mauaie MN, Buene T, Funzamo CA, et al. A
cross-sectional serological study of cysticercosis, schistosomiasis, toxocariasis and echinococcosis in
HIV-1 infected people in Beira, Mozambique. PLoS Negl Trop Dis. 2014; 8:e3121. https://doi.org/10.
1371/journal.pntd.0003121 PMID: 25188395
16. Ministério da Saúde. Norma de tratamento da epilepsia. 2016; 24 p. República de Moçambique.
17. Noormahomed EV, Mandane A, Cuambe A, Rodrigues MA, Noormahomed S, Carrilho C, et al. Design
and Implementation of Postgraduate Programs in Health in a Resource-Limited Setting in Mozambique
(The Lurio University). Adv Med Educ Pract. 2021; 12:399–412. https://doi.org/10.2147/AMEP.
S291364 PMID: 33911914
18. Muadica AS, Balasegaram S, Beebeejaun K, Köster PC, Bailo B, Hernández-de-Mingo M, et al. (2021).
Risk associations for intestinal parasites in symptomatic and asymptomatic schoolchildren in central
Mozambique. Clin Microb Infect. 2021; 27(4):624–629. https://doi.org/10.1016/j.cmi.2020.05.031
PMID: 32505583
19. Grau-Pujol B, Massangaie M, Cano J, Maroto C, Ndeve A, Saute F, et al. Frequency and distribution of
neglected tropical diseases in Mozambique: a systematic review. Infect Dis Poverty. 2019; 8:103.
https://doi.org/10.1186/s40249-019-0613-x PMID: 31836025
20. Noormahomed EV, Akrami K, Mascaro-Lazcano C. Onchocerciasis, an undiagnosed disease in
Mozambique: identifying research opportunities. Parasit Vectors. 2016; 9:180. https://doi.org/10.1186/
s13071-016-1468-7 PMID: 27030247
21. Noormahomed EV, Mascaro-Lazcano C. Onchocerciasis in Mozambique: An unknown condition for
health professionals. EC Microbiol; 2019. 15;160–167. PMID: 30957099
22. INE. Folheto Estatistico Distrital Mocuba 2018; 2022. Available at: http://www.ine.gov.mz/estatisticas/
publicacoes/folheto-distrital/zambezia/411-folhetos-dpine-mocuba-2018.pdf/at_download/file.
Accessed: April 10, 2022.
23. Daniel WW. Biostatistics: A Foundation for Analysis in the Health Sciences. 1999. New York: John
Wiley & Sons.
24. Patel V, Simbine AP, Soares IC, Weiss HA, Wheeler E. Prevalence of severe mental and neurological
disorders in Mozambique: a population-based survey. Lancet. 2007; 370:1055–1060. https://doi.org/10.
1016/S0140-6736(07)61479-2 PMID: 17889244
25. Cysticercosis Working Group in Eastern and Southern Africa. Declaration on Taenia solium cysticerco-
sis/taeniosis. Acta Tropica. 2003; 87:1–2. https://doi.org/10.1016/S0001-706X(03)00049-4
26. Jane Shaw S. How to undertake venepuncture to obtain venous blood samples. Nurs Stand. 2018; 32
(29):41–47. https://doi.org/10.7748/ns.2018.e10531 PMID: 29537759
27. Nkouawa A, Dschanou AR, Moyou-Somo R, Sako Y, Ito A. Seroprevalence and risk factors of human
cysticercosis and taeniasis prevalence in a highly endemic area of epilepsy in Bangoua, west Camer-
oon. Acta tropica. 2017; 165:116–120. https://doi.org/10.1016/j.actatropica.2015.12.019 PMID:
26747010
28. Edia-Asuke AU, Inabo HI, Mukaratirwa S, Umoh VJ, Whong CM, Asuke S, et al. Seroprevalence of
human cysticercosis and its associated risk factors among humans in areas of Kaduna metropolis,
Nigeria. J Infect Dev Ctries. 2015; 9:799–805. https://doi.org/10.3855/jidc.5415 PMID: 26322870
29. Nguyen T, Cheong FW, Liew JW, Lau YL. Seroprevalence of fascioliasis, toxocariasis, strongyloidiasis
and cysticercosis in blood samples diagnosed in Medic Medical Center Laboratory, Ho Chi Minh City,
Vietnam in 2012. Parasit Vectors. 2016; 9(1):486. https://doi.org/10.1186/s13071-016-1780-2 PMID:
27595647
30. Binh VTL, Dung DT, Vinh HQ, Anke VH, Nicolas P, Pierre D, et al. Human Taeniasis and Cysticercosis
and Related Factors in Phu Tho Province, Northern Vietnam. Korean J Parasitol 2021; 59(4):369–376.
https://doi.org/10.3347/kjp.2021.59.4.369 PMID: 34470088
31. Mwape KE, Phiri IK, Praet N, Muma JB, Zulu G, Van den Bossche P, et al. Taenia solium Infections in a
rural area of Eastern Zambia-a community based study. PLoS Negl Trop Dis. 2012; 6(3):e1594. https://
doi.org/10.1371/journal.pntd.0001594 PMID: 22479664
32. Ito A, Yamasaki H, Nakao M, Sako Y, Okamoto M, Sato MO, et al. Multiple genotypes of Taenia solium
—ramifications for diagnosis, treatment and control. Acta Trop. 2003; 87:95–101. https://doi.org/10.
1016/s0001-706x(03)00024-x PMID: 12781383
33. Palafox-Fonseca H, Zuniga G, Bobes RJ, Govezensky T, Pinero D, Texco-Martinez L, et al. Genetic
variation in the Cytb gene of human cerebral Taenia solium cysticerci recovered from clinically and
radiologically heterogeneous patients with neurocysticercosis. Mem Inst Oswaldo Cruz. 2013;
108:914–920. https://doi.org/10.1590/0074-0276130308 PMID: 24271046
34. Tsang VC, Brand JA, Boyer AE. An enzyme-linked immunoelectrotransfer blot assay and glycoprotein
antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis. 1989; 159: 50–59. https://
doi.org/10.1093/infdis/159.1.50 PMID: 2909643
35. Rodriguez S, Wilkins P, Dorny P. Immunological and molecular diagnosis of cysticercosis. Pathog Glob
Health. 2012, 106:286–298. https://doi.org/10.1179/2047773212Y.0000000048 PMID: 23265553
36. Direcção Provincial de Saúde da Zambézia, Programa de Saúde Mental. 2019. Relatório annual de
Saúde Mental.
37. Wagenaar BH, Cumbe V, Raunig-Berho M, Rao D, Kohrt BA, Stergachis A, et al. Outpatient mental
health services in Mozambique: use and treatments. Psychiatr Serv. 2016; 67:588–590. https://doi.org/
10.1176/appi.ps.201500508 PMID: 26828400
38. Dos Santos PF, Cumbe V, Gouveia ML, de Fouchier C, Teuwen D, Dua T. Implementation of mhGAP
in Mozambique: integrating epilepsy care into the primary health care system. Int J Ment Health Syst.
2019; 13:36. https://doi.org/10.1186/s13033-019-0296-5 PMID: 31160920
39. Secka A, Marcotty T, De Deken R, Van Marck E, Geerts S. Porcine cysticercosis and risk factors in the
Gambia and Senegal. J Parasitol Res. 2010;823892. https://doi.org/10.1155/2010/823892 PMID:
20981349
40. Quet F, Guerchet M, Pion SD, Ngoungou EB, Nicoletti A, Preux PM. Meta-analysis of the association
between cysticercosis and epilepsy in Africa. Epilepsia. 2010; 51:830–837. https://doi.org/10.1111/j.
1528-1167.2009.02401.x PMID: 19919664
41. Debacq G, Moyano LM, Garcia HH, Boumediene F, Marin B, Ngoungou EB, et al. Systematic review
and meta-analysis estimating association of cysticercosis and neurocysticercosis with epilepsy. PLoS
Negl Trop Dis. 2017; 11:e0005153. https://doi.org/10.1371/journal.pntd.0005153 PMID: 28267746
42. Sahlu I, Carabin H, Ganaba R, Preux PM, Cisse AK, Tarnagda Z, et al. Estimating the association
between being seropositive for cysticercosis and the prevalence of epilepsy and severe chronic head-
aches in 60 villages of rural Burkina Faso. PLoS Negl Trop Dis. 2019; 13:e0007101. https://doi.org/10.
1371/journal.pntd.0007101 PMID: 30677038
43. Mwanjali G, Kihamia C, Kakoko DV, Lekule F, Ngowi H, Johansen MV, et al. Prevalence and risk factors
associated with human Taenia solium infections in Mbozi District, Mbeya Region, Tanzania. PLoS Negl
Trop Dis. 2013; 7(3):e2102. https://doi.org/10.1371/journal.pntd.0002102 PMID: 23516650
44. Toquero M, Morocoima A, Ferrer E. [Seroprevalence and risk factors of cysticercosis in two rural com-
munities in Anzoátegui state, Venezuela]. Biomedica. 2017;1, 37(0):66–74. https://doi.org/10.7705/
biomedica.v37i2.2841 PMID: 28527268
45. Trung DD, Praet N, Cam TD, Lam BV, Manh HN, Gabriël S, et al. Assessing the burden of human cysti-
cercosis in Vietnam. Trop Med Int Health. 2013; 18(3):352–6. https://doi.org/10.1111/tmi.12043 PMID:
23279716
46. Chung JY, Eom KS, Yang Y, Li X, Feng Z, Rim HJ, et al. A seroepidemiological survey of Taenia solium
cysticercosis in Nabo, Guangxi Zhuang Autonomous Region, China. Korean J Parasitol. 2005; 43
(4):135–9. https://doi.org/10.3347/kjp.2005.43.4.135 PMID: 16340302
47. Greene MC, Yangchen T, Lehner T, Sullivan PF, Pato CN, McIntosh A, et al. The epidemiology of psy-
chiatric disorders in Africa: a scoping review. Lancet Psychiatry. 2021; 8(8):717–731. https://doi.org/10.
1016/S2215-0366(21)00009-2 PMID: 34115983
48. Forrester JV, McMenamin PG, Dando SJ. CNS infection and immune privilege. Nat Rev Neurosci.
2018; 19(11):655–671. https://doi.org/10.1038/s41583-018-0070-8 PMID: 30310148
49. Manuel L, Santos-Gomes G, Noormahomed EV. Human toxoplasmosis in Mozambique: gaps in knowl-
edge and research opportunities. Parasit Vectors. 2020; 13:571. https://doi.org/10.1186/s13071-020-
04441-3 PMID: 33176884
50. Noormahomed EV, Mocumbi AO, Ismail M, Carrilho C, Patel S, Nguenha A, et al. The medical educa-
tion partnership initiative effect on increasing health professions education and research capacity in
Mozambique. Ann Glob Health. 2018; 84:47–57. https://doi.org/10.29024/aogh.14 PMID: 30873790
51. Nachega JB, Grimwood A, Mahomed H, Fatti G, Preiser W, Kallay O, et al. From Easing Lockdowns to
Scaling Up Community-based Coronavirus Disease 2019 Screening, Testing, and Contact Tracing in
Africa-Shared Approaches, Innovations, and Challenges to Minimize Morbidity and Mortality. Clin Infect
Dis. 2021; 72:327–331. https://doi.org/10.1093/cid/ciaa695 PMID: 33501963
52. Cliff J, Noormahomed AR. Health as a target: South Africa’s destabilization of Mozambique. Soc Sci
Med. 1988; 27:717–722. https://doi.org/10.1016/0277-9536(87)90331-5 PMID: 3227373
53. Morina N, Akhtar A, Barth J, Schnyder U. Psychiatric Disorders in Refugees and Internally Displaced
Persons After Forced Displacement: A Systematic Review. Front Psychiatry. 2018; 9:433. https://doi.
org/10.3389/fpsyt.2018.00433 PMID: 30298022
54. Cavellani CL, Faleiros AC, Lino Rde S Jr, Dos Reis MA, Teixeira V. Cysticercosis in the elderly. Ann
Diagn Pathol. 2007: 11(5): 330–333. https://doi.org/10.1016/j.anndiagpath.2006.12.008 PMID:
17870018
55. Galipó E, Dixon MA, Fronterrè C, Cucunubá ZM, Basáñez MG, Stevens K, et al. Spatial distribution and
risk factors for human cysticercosis in Colombia. Parasites Vectors. 2021; 14:590. https://doi.org/10.
1186/s13071-021-05092-8 PMID: 34838117
56. Praet N, Speybroeck N, Rodriguez-Hidalgo R, Benitez-Ortiz W, Berkvens D, Brandt J, et al. Age-related
infection and transmission patterns of human cysticercosis. Int J Parasitol. 2010; 40(1):85–90. https://
doi.org/10.1016/j.ijpara.2009.07.007 PMID: 19683531
57. Moyano LM O’Neal SE, Ayvar V, Gonzalvez G, Gamboa R, Vilchez P, et al. High Prevalence of Asymp-
tomatic Neurocysticercosis in an Endemic Rural Community in Peru. PLoS Negl Trop Dis. 2016; 10
(12):e0005130. https://doi.org/10.1371/journal.pntd.0005130 PMID: 27992429
58. Carabin H, Millogo A, Cisse A, Gabriel S, Sahlu I, Dorny P, et al. Prevalence of and Factors Associated
with Human Cysticercosis in 60 Villages in Three Provinces of Burkina Faso. PLoS Negl Trop Dis.
2015; 9:e0004248. https://doi.org/10.1371/journal.pntd.0004248 PMID: 26588468
59. Coral-Almeida M, Gabriël S, Abatih EN, Praet N, Benitez W, Dorny P. Taenia solium Human Cysticer-
cosis: A Systematic Review of Sero-epidemiological Data from Endemic Zones around the World.
PLoS Negl Trop Dis. 2015; 9(7): e0003919. https://doi.org/10.1371/journal.pntd.0003919 PMID:
26147942
60. Goodman KA, Ballagh SA, Carpio A. Case-control study of seropositivity for cysticercosis in Cuenca,
Ecuador. Am J Trop Med Hyg. 1999; 60(1):70–4. https://doi.org/10.4269/ajtmh.1999.60.70 PMID:
9988326
61. Rebecca WP, Eugene II, Joshua K. Seroprevalence of antibodies (IgG) to Taenia solium among pig
rearers and associated risk factors in Jos metropolis, Nigeria. J Infect Dev Ctries. 2013; 7:67–72.
https://doi.org/10.3855/jidc.2309 PMID: 23416651